Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The daily Top 10 COVID papers

Ovarian Neoplasms

Free Subscription 30.11.2020 2 Am J Obstet Gynecol 1 Cancer Lett 8 Gynecol Oncol 1 Int J Cancer 1 Int J Gynaecol Obstet 4 Oncogene

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. FERRARI F, Forte S, Sbalzer N, Zizioli V, et al
   Validation of an enhanced recovery after surgery protocol in gynecological surgery: an Italian randomized study.
   Am J Obstet Gynecol. 2020 Jul 8. pii: S0002-9378(20)30720.
   PubMed         Abstract available
   
   
2. MILLER H, Matsuo K
   A cesarean delivery sequela: Scar rupture and tumor spill during laparoscopic hysterectomy for endometrial cancer.
   Am J Obstet Gynecol. 2020 Mar 18. pii: S0002-9378(20)30337.
   PubMed        
   
   

   
   Cancer Lett

3. MOSKOVICH D, Alfandari A, Finkelshtein Y, Weisz A, et al
   DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer.
   Cancer Lett. 2020 Nov 19. pii: S0304-3835(20)30603.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

4. XU Y, Jia Y, Zhang Q, Du Y, et al
   Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
   Gynecol Oncol. 2020 Nov 18. pii: S0090-8258(20)34121.
   PubMed         Abstract available
   
   
5. DI DONATO V, Di Pinto A, Giannini A, Caruso G, et al
   Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer.
   Gynecol Oncol. 2020 Sep 4. pii: S0090-8258(20)33823.
   PubMed         Abstract available
   
   
6. RANA HQ, Kipnis L, Hehir K, Cronin A, et al
   Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
   Gynecol Oncol. 2020 Nov 20. pii: S0090-8258(20)34111.
   PubMed         Abstract available
   
   
7. MORSE CB, Voillet V, Bates BM, Chiu EY, et al
   Development of a clinically relevant ovarian cancer model incorporating surgical cytoreduction to evaluate treatment of micro-metastatic disease.
   Gynecol Oncol. 2020 Nov 20. pii: S0090-8258(20)34117.
   PubMed         Abstract available
   
   
8. FEJZO MS, Chen HW, Anderson L, McDermott MS, et al
   Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition.
   Gynecol Oncol. 2020 Nov 20. pii: S0090-8258(20)34116.
   PubMed         Abstract available
   
   
9. KHATIB G, Seyfettinoglu S, Guzel AB, Gulec UK, et al
   Feasibility and rationale of a novel approach in advanced ovarian cancer surgery: Bat- shaped en-bloc total peritonectomy and total hysterectomy salpingo-oophorectomy with or without rectosigmoid resection (Sarta-Bat approach).
   Gynecol Oncol. 2020 Nov 21. pii: S0090-8258(20)34122.
   PubMed         Abstract available
   
   
10. CHELARIU-RAICU A, Nick A, Urban R, Gordinier M, et al
    A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer.
    Gynecol Oncol. 2020 Nov 23. pii: S0090-8258(20)34124.
    PubMed         Abstract available
    
    
11. CONSIDINE DPC, Jia G, Shu X, Schildkraut JM, et al
    Genetically predicted circulating protein biomarkers and ovarian cancer risk.
    Gynecol Oncol. 2020 Nov 24. pii: S0090-8258(20)34127.
    PubMed         Abstract available
    
    

    
    Int J Cancer

12. AN Y, Yang Q
    Tumor-associated macrophage targeted therapeutics in ovarian cancer.
    Int J Cancer. 2020 Nov 24. doi: 10.1002/ijc.33408.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

13. TAKEDA T, Hayashi S, Kobayashi Y, Tsuji K, et al
    Evaluation of preoperative prediction of intestinal invasion in patients with ovarian cancer.
    Int J Gynaecol Obstet. 2020 Nov 22. doi: 10.1002/ijgo.13492.
    PubMed         Abstract available
    
    

    
    Oncogene

14. LI J, Alvero AB, Nuti S, Tedja R, et al
    CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential.
    Oncogene. 2020;39:3965-3979.
    PubMed         Abstract available
    
    
15. TAMURA R, Yoshihara K, Nakaoka H, Yachida N, et al
    XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary.
    Oncogene. 2020 Mar 2. pii: 10.1038/s41388-020-1237.
    PubMed         Abstract available
    
    
16. HAYASHI T, Sano K, Aburatani H, Yaegashi N, et al
    Initialization of epithelial cells by tumor cells in a metastatic microenvironment.
    Oncogene. 2020;39:2638-2640.
    PubMed        
    
    
17. CLUZET V, Devillers MM, Petit F, Chauvin S, et al
    Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.
    Oncogene. 2019 Nov 19. pii: 10.1038/s41388-019-1109.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: